240 related articles for article (PubMed ID: 19724022)
21. Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines.
Meng ZX; Yin Y; Lv JH; Sha M; Lin Y; Gao L; Zhu YX; Sun YJ; Han X
Diabetologia; 2012 Jun; 55(6):1733-44. PubMed ID: 22415588
[TBL] [Abstract][Full Text] [Related]
22. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1.
Jung YA; Kim HK; Bae KH; Seo HY; Kim HS; Jang BK; Jung GS; Lee IK; Kim MK; Park KG
Exp Mol Med; 2014 Jan; 46(1):e73. PubMed ID: 24458133
[TBL] [Abstract][Full Text] [Related]
23. Regulation of bile acid, cholesterol, and fatty acid synthesis in chicken primary hepatocytes by different concentrations of T0901317, an agonist of liver X receptors.
Sato K; Kamada T
Comp Biochem Physiol A Mol Integr Physiol; 2011 Feb; 158(2):201-6. PubMed ID: 21056113
[TBL] [Abstract][Full Text] [Related]
24. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR.
Cha JY; Repa JJ
J Biol Chem; 2007 Jan; 282(1):743-51. PubMed ID: 17107947
[TBL] [Abstract][Full Text] [Related]
25. LXR agonist T0901317-Induced hyperlipidemia does not lead to lipid accumulation in the rat heart.
Harasiuk D; Baranowski M; Zabielski P; Chabowski A; Górski J
Cell Physiol Biochem; 2015; 35(3):1095-106. PubMed ID: 25659329
[TBL] [Abstract][Full Text] [Related]
26. Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRα-SREBP1c-dependent mechanism.
Zhang X; Liu J; Su W; Wu J; Wang C; Kong X; Gustafsson JÅ; Ding J; Ma X; Guan Y
J Diabetes; 2014 May; 6(3):212-20. PubMed ID: 23945440
[TBL] [Abstract][Full Text] [Related]
27. Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1.
Briand O; Touche V; Colin S; Brufau G; Davalos A; Schonewille M; Bovenga F; Carrière V; de Boer JF; Dugardin C; Riveau B; Clavey V; Tailleux A; Moschetta A; Lasunción MA; Groen AK; Staels B; Lestavel S
Gastroenterology; 2016 Mar; 150(3):650-8. PubMed ID: 26602218
[TBL] [Abstract][Full Text] [Related]
28. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
[TBL] [Abstract][Full Text] [Related]
29. A role for protein inhibitor of activated STAT1 (PIAS1) in lipogenic regulation through SUMOylation-independent suppression of liver X receptors.
Zhang Y; Gan Z; Huang P; Zhou L; Mao T; Shao M; Jiang X; Chen Y; Ying H; Cao M; Li J; Li J; Zhang WJ; Yang L; Liu Y
J Biol Chem; 2012 Nov; 287(45):37973-85. PubMed ID: 22969086
[TBL] [Abstract][Full Text] [Related]
30. Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice.
Zhang Y; Breevoort SR; Angdisen J; Fu M; Schmidt DR; Holmstrom SR; Kliewer SA; Mangelsdorf DJ; Schulman IG
J Clin Invest; 2012 May; 122(5):1688-99. PubMed ID: 22484817
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity.
Kim KH; Lee GY; Kim JI; Ham M; Won Lee J; Kim JB
J Lipid Res; 2010 Dec; 51(12):3425-33. PubMed ID: 20847297
[TBL] [Abstract][Full Text] [Related]
32. Dietary phosphate restriction induces hepatic lipid accumulation through dysregulation of cholesterol metabolism in mice.
Tanaka S; Yamamoto H; Nakahashi O; Kagawa T; Ishiguro M; Masuda M; Kozai M; Ikeda S; Taketani Y; Takeda E
Nutr Res; 2013 Jul; 33(7):586-93. PubMed ID: 23827134
[TBL] [Abstract][Full Text] [Related]
33. Elimination of macrophages drives LXR-induced regression both in initial and advanced stages of atherosclerotic lesion development.
van der Stoep M; Li Z; Calpe-Berdiel L; van der Sluis RJ; Saleh P; McKinnon HJ; Smit MJ; Korporaal SJ; Van Berkel TJ; Van Eck M; Hoekstra M
Biochem Pharmacol; 2013 Dec; 86(11):1594-602. PubMed ID: 24095721
[TBL] [Abstract][Full Text] [Related]
34. Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317.
Peng D; Hiipakka RA; Reardon CA; Getz GS; Liao S
Atherosclerosis; 2009 Mar; 203(1):59-66. PubMed ID: 18639878
[TBL] [Abstract][Full Text] [Related]
35. Reduced insulin-mediated inhibition of VLDL secretion upon pharmacological activation of the liver X receptor in mice.
Grefhorst A; Parks EJ
J Lipid Res; 2009 Jul; 50(7):1374-83. PubMed ID: 19287042
[TBL] [Abstract][Full Text] [Related]
36. Intrauterine metabolic programming alteration increased susceptibility to non-alcoholic adult fatty liver disease in prenatal caffeine-exposed rat offspring.
Wang L; Shen L; Ping J; Zhang L; Liu Z; Wu Y; Liu Y; Huang H; Chen L; Wang H
Toxicol Lett; 2014 Jan; 224(3):311-8. PubMed ID: 24239806
[TBL] [Abstract][Full Text] [Related]
37. Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover.
Green CD; Jump DB; Olson LK
Endocrinology; 2009 Jun; 150(6):2637-45. PubMed ID: 19228891
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol.
Grefhorst A; Oosterveer MH; Brufau G; Boesjes M; Kuipers F; Groen AK
Atherosclerosis; 2012 Jun; 222(2):382-9. PubMed ID: 22481067
[TBL] [Abstract][Full Text] [Related]
39. Feedback modulation of cholesterol metabolism by the lipid-responsive non-coding RNA LeXis.
Sallam T; Jones MC; Gilliland T; Zhang L; Wu X; Eskin A; Sandhu J; Casero D; Vallim TQ; Hong C; Katz M; Lee R; Whitelegge J; Tontonoz P
Nature; 2016 Jun; 534(7605):124-8. PubMed ID: 27251289
[TBL] [Abstract][Full Text] [Related]
40. LXRalpha regulates human CETP expression in vitro and in transgenic mice.
Honzumi S; Shima A; Hiroshima A; Koieyama T; Ubukata N; Terasaka N
Atherosclerosis; 2010 Sep; 212(1):139-45. PubMed ID: 20494359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]